We are pleased to announce that the third edition of MIIM will take place on November 18th and 19th, 2026, at the DUMONTET Auditorium in the Faculty of Sciences in Montpellier.

 

This conference, organized by the Infectiology & Immunology axis of the "Health Biology" Pole of the Université de Montpellier, specifically provides a platform for young researchers (Ph.D. students, postdoctoral researchers, etc.) to bring together and promote exchanges among the various protagonists in clinical and fundamental research in infectious diseases and immunology in the Montpellier area, while deepening our knowledge in these fields.

Our talented PhD and post-doctoral students will present their research to the community through 15-minute oral presentation (12' + 3') or posters.

 

 

Registration is free but mandatory and a buffet lunch will be provided for participants on November 19th. 

You can now register in the “Registration” section and submit your abstracts (500 words maximum, in English) via your personal account under “My submissions.”

Submission deadline: October 21th, 2026

Registration deadline: November 4th, 2026

 

• Host-pathogen interactions, from the environment to the cell

(Bacteriology / Virology / Parasitology / Mycology / Microbiota / Epidemiology / Evolution / AMR)

• Signaling in epithelial and immune cells

(Cell death / Tissues / Innate and adaptive immunity / Signaling pathways / Autophagy / Metabolism)

• New biotechnologies in infection and immunology

(Nanotechnologies / Organoids / CRISPR / Immunotherapies / Alternative antibiotic therapies / Multi-omics)

Cyrille Mathieu, CIRI, Lyon, France

Study of the molecular mechanisms that influence the ability of viruses to enter and spread within the central nervous system, and how brain tissue or treatments may influence the virus’ progression.

https://ciri.ens-lyon.fr/teams/nitrovire

 

 

 

Molly Ingersoll, Institut Cochin, Paris, France

Study of innate and adaptive immune responses against urinary tract infections (UTIs) and bladder cancer to identify targets for treating multidrug-resistant UTIs and to understand the response to immunotherapies for bladder cancer.

https://institutcochin.fr/equipes/inflammation-immunite-muqueuses

 

 

 

Simona Huwiler, University of Bern, Switzerland

Learning from predatory bacteria (Bdellovibrio bacteriovorus) as a source of novel therapeutics agents: from 'omics' to molecular mechanisms.

https://simona-huwiler.net/